Matinas BioPharma Holdings, Inc
Financing
SEC filings to 2026-10-05 · every row opens its filingShares on issue
6.41M
on 2026-06-30, from 4.35M on 2024-03-31 10-Q ↗
Earlier counts are adjusted for the 1-for-50 reverse split; each bar's tip shows the count as filed.
a raise that quarter, at its price
2 of its filings are not read yet.
Warrants
The 10-Q filed 2026-08-13 is not read yet.
Cash
0.5 quarters
$761K on 2026-06-30 ÷ $1.6M a quarter of operating cash used, the average of four quarters. 10-Q ↗
| Date | What | Shares | Price | Gross | Filing |
|---|---|---|---|---|---|
| 2026-07-10 | Private placement | 575 | not read | $575K | 8-K ↗ |
| 2025-02-13 | Private placement | 3,300 | not read | $1.6M | 8-K ↗ |
Also on file: a 1-for-15 reverse split, 2026-09-25 8-K ↗